Pazufloxacin
Pazufloxacin structure
|
Common Name | Pazufloxacin | ||
|---|---|---|---|---|
| CAS Number | 127045-41-4 | Molecular Weight | 318.300 | |
| Density | 1.6±0.1 g/cm3 | Boiling Point | 531.5±50.0 °C at 760 mmHg | |
| Molecular Formula | C16H15FN2O4 | Melting Point | 269-271°C | |
| MSDS | Chinese USA | Flash Point | 275.2±30.1 °C | |
| Symbol |
GHS07 |
Signal Word | Warning | |
|
[Pharmacological properties and expected clinical role of an injectable new quinolone antibiotic, pazufloxacin mesilate].
Nippon. Yakurigaku Zasshi. 122(2) , 161-78, (2003) Pazufloxacin mesilate (PZFX: Pasil INJECTION, Pazucross INJECTION) is a novel injectable quinolone antibiotic that was discovered by Toyama Chemical Co., Ltd. and codeveloped by Toyama Chemical Co. Ltd. and Mitsubishi Pharma Corporation. Laboratory studies in... |
|
|
Pazufloxacin Toyama Chemical Co.
Curr. Opin. Investig. Drugs 1(1) , 52-7, (2000) Toyama Chemical Co Ltd is developing pazufloxacin (T-3761), an orally active synthetic quinolone antibiotic, which is awaiting registration following successful clinical trials that demonstrated its pharmacological similarities to tosufloxacin (Toyama Chemica... |
Journals:
More...